Business Wire

RAM Active Investments Launches the RAM Diversified Alpha Fund (UCITS)

Share

RAM Active Investments SA ("RAM AI"), a systematic asset manager based in Geneva, is launching the RAM (LUX) SYSTEMATIC FUNDS – DIVERSIFIED ALPHA (the “Fund”), a fund which will seek to deploy a robust and stable systematic investment process to exploit volatility and dispersion within a broadly diversified global asset allocation, with the intention of offering asymmetric returns that have low correlation to global markets.

“Technological innovation is a key component of the portfolio construction methodology”, explains Maxime Botti, Founding Partner & Senior Fund Manager at RAM AI who heads the systematic macro team formed by Philippe Huber and Tony Guida, Fund Managers and Researchers. “We used a similar methodology than our Alternative Investment Fund strategy which has the objective to provide uncorrelated returns to mainstream asset classes over the medium-term”.

The Fund aims at acting as a real diversifier in a global asset allocation by seeking to deliver absolute returns, not only during normal market conditions but also when it is the most needed during market jolt periods.

The approach to dispersion modelling is agnostic and adaptive. RAM AI models the relationships between liquid assets by analysing them on a relative basis and through multiple dimensions. RAM AI’s expansive and evolving computational capabilities allow to analyse on an ongoing basis a large amount of data to identify the most profitable strategies across time frames spanning from short to long-term.

“Relying on techniques borrowed from natural sciences for solving multi-dimensional problems, the use of genetic algorithm that replicates evolution allows our models to select the fittest alphas, making the overall strategy more robust” adds Philippe Huber.

As financial markets change (less independent, central banks interventions, etc.), so does our model” shares Tony Guida. The Fund benefits from a robust process of alpha creation and selection; alphas are reassessed several times per year to take into account evolving market conditions.

The Fund is available in a UCITS format as of the 10th of November 2020 to investors in France, Finland, Germany, Italy, Luxembourg, Norway, Portugal, Sweden, Switzerland and United Kingdom.

RAM Active Investments

RAM Active Investments is a systematic asset manager with a long experience in creating value for its customers in any market condition. Research is at the heart of our disciplined approach to investment, which enables us to identify and continually exploit new market inefficiencies by adopting the latest innovative technologies.

Founded in 2007 by Thomas de Saint-Seine, Maxime Botti and Emmanuel Hauptmann, RAM Active Investments, an affiliate of Mediobanca Group since March 2018, operates independently worldwide with more than 40 employees and four offices in Geneva (headquarter), Zurich, Luxembourg and Milan. Asset under Management of USD 2 billion as of end of June 2020.

To find out more about RAM Active Investments visit the website ram-ai.com or follow us on LinkedIn.

About the team

Philippe Huber joined RAM AI in 2017 as a Senior Quantitative Analyst to work on the development of systematic investment strategies. In 2020, he became Fund Manager of the RAM Diversified Alpha and continues his focus on the development of a proprietary suite of back testing and non-traditional optimisation tools in Cuda/C++ to run on GPUs.

Philippe is an award-winning PhD in Econometrics and Statistics (University of Geneva, 2004), a graduate of the EPFL (MSc, Physics, 1998) and a graduate of the University of Geneva (MSc, Econometrics and Statistics, 2001).

Tony Guida joined RAM AI in 2019 as a Senior Quantitative Researcher and became Fund Manager of the Diversified Alpha in 2020. His work focuses primarily on extracting market inefficiencies from different sources from traditional fundamentals, market signals, alternative data, and machine learning. His expertise is in mid to low frequency in equities.

Tony started his career at Unigestion in the quantitative equity low volatility team and later became a member of the research and investment committee for Minimum Variance Strategies, where he led the factor investing research group for institutional clients. In 2015, he moved to Edhec Risk Scientific Beta as a Senior Consultant for Risk allocation and factor strategies before going to a major UK pension fund in 2016 to build the in-house systematic equity, co-managing 6 billion GBP as a senior quantitative portfolio manager.

Philippe and Tony have a number of publications under their names in some of the best academic research journals, including the recently published “Genetic Algorithms: A heuristic approach to multi-dimensional problems”.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Lidia Marqués
Head of Communications & Events
Email: ram-communication@ram-ai.com
Phone: +41 58 726 87 27

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kyowa Kirin Provides Update on Application for Marketing Authorisation of Istradefylline in Europe for the Treatment of ‘OFF’ Episodes in People Living with Parkinson’s23.7.2021 16:05:00 CEST | Press release

Kyowa Kirin Co., Ltd. (TSE:4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion for istradefylline as an add-on treatment to levodopa (L-Dopa) based regimens in adults living with Parkinson’s, experiencing end-of-dose motor fluctuations. Kyowa Kirin International remain committed to istradefylline and people living with Parkinson’s and are currently reviewing the options available, which may include re-examination. “We are disappointed by the CHMP opinion. However, we remain confident in the benefit-risk profile of istradefylline and are committed to making a difference to the lives of people living with Parkinson’s, an area which has had few innovative therapies for decades,” said Abdul Mullick, President of Kyowa Kirin International. “There are currently few new treatment options available to manage end-of-dose motor fluctuations in Parkinson

ForumPay Teams Up with Bambora to Conquer the Crypto-to-Fiat Payments Market23.7.2021 15:16:00 CEST | Press release

ForumPay, an international cryptocurrency-to-fiat payment service provider, has established a partnership with the global payments provider Bambora, a Worldline brand, to bring seamless crypto payment solutions to merchants and online shoppers. The partnership will cater to a large global audience and offer expanded payment options for both shoppers and merchants. ForumPay continues its march to dominate the growing crypto payments ecosystem for merchants around the world. “ForumPay provides merchants with a seamless, secure and instant processing solution to accept payments from the more than 54 million active crypto wallet users around the world. By providing a payments service for processing crypto into fiat that functions as naturally as card payments, ForumPay enables merchants with a familiar feeling payments alternative that also gives them a competitive advantage by tapping into the fastest growing consumer base on the planet.” says Joshua Tate, CEO of ForumPay. “We are very ex

Wipro Recognized as 2021 Microsoft Modernizing Applications Partner of the Year23.7.2021 14:54:00 CEST | Press release

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it has won the 2021 Microsoft Partner of the Year Award in the Modernizing Applications category. In addition, Wipro was also named as a category finalist in the 2021 AI Partner of the Year category, solidifying its reputation as an innovator in multiple sectors. This recognition highlights Wipro’s deep expertise and ability to go above and beyond for its customers, powered by an established partnership with Microsoft. Even when working with complex customer environments, spanning across hundreds of servers with different applications of different versions, Wipro was able to help customers meet their business needs and leverage the power of public cloud in an efficient way. “Global enterprises have embraced modernization at an unprecedented scale and pace, and the demands of the past year show no sign of easing. We are honor

Merck Announces Appointment of Head of China & International for Healthcare23.7.2021 13:45:00 CEST | Press release

Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will lead China, Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism & Endocrinology (CM&E), and the Global Business Innovation team. Chow will report to Peter Guenter, Member of the Executive Board of Merck and CEO Healthcare. She will serve as a member of the Healthcare Executive Committee, and be based in Shanghai, China. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210723005186/en/ Merck Announces Appointment of Head of China & International for Healthcare (Photo: Business Wire) “Hong’s international experience and strong track record of bringing innovative medicines to patients in need across both developed and emerging markets, most nota

H.I.G. WhiteHorse Refinances Grupo Recoletas23.7.2021 13:03:00 CEST | Press release

H.I.G. WhiteHorse, a credit affiliate of global investment firm H.I.G. Capital ("H.I.G.") is pleased to announce that it has arranged a refinancing package for Grupo Hospitalario Recoletas (“Recoletas”), which includes a significant growth capital component. Recoletas is a family-owned Spanish private hospital operator headquartered in Valladolid, Spain, with a leading position in the Castilla y Leon Spanish inland region. It operates 8 hospitals with c. 540 beds and 13 medical centres across 7 regions. H.I.G. WhiteHorse has committed €110 million in unitranche loans to refinance the borrower's existing indebtedness and provide additional capital to finance growth, supporting the Company’s expansion. Recoletas is currently developing ambitious projects to expand its healthcare services provided through hospitals and medical centers, as well as diagnostic imaging centers and radiotherapy units. Amando J. Rodríguez, President and CEO of Grupo Hospitalario Recoletas, said: “We are very ha

Schlumberger Announces Second-Quarter 2021 Results23.7.2021 12:50:00 CEST | Press release

Schlumberger Limited (NYSE: SLB) today reported results for the second-quarter 2021. Second-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeJun. 30, 2021Mar. 31, 2021Jun. 30, 2020SequentialYear-on-yearRevenue* $5,634 $5,223 $5,356 8% 5% Income (loss) before taxes - GAAP basis $542 $386 $(3,627) 40% n/m Net income (loss) - GAAP basis $431 $299 $(3,434) 44% n/m Diluted EPS (loss per share) - GAAP basis $0.30 $0.21 $(2.47) 43% n/m Adjusted EBITDA** $1,198 $1,049 $838 14% 43% Adjusted EBITDA margin** 21.3% 20.1% 15.6% 118 bps 561 bps Pretax segment operating income** $807 $664 $396 22% 104% Pretax segment operating margin** 14.3% 12.7% 7.4% 162 bps 694 bps Net income, excluding charges & credits** $431 $299 $69 44% 525% Diluted EPS, excluding charges & credits** $0.30 $0.21 $0.05 43% 500% Revenue by Geography International $4,511 $4,211 $4,224 7% 7% North America* 1,083 972 1,097 11% -1% Other 40 40 35 n/m n/m $5,634 $5,223 $5,356 8% 5% *Schlumberger di

Wyss Center Partners With Artiria Medical to Accelerate a Novel Therapy for Cerebral Vasospasm23.7.2021 11:59:00 CEST | Press release

The Wyss Center and Artiria Medical today announced a new partnership to accelerate the translation of a novel technology that has the potential to reduce deaths and improve quality of life for stroke patients. Artiria Medical, an early-stage medical device company focused on disruptive neurovascular products, has been developing the technology and is now joining forces with the Wyss Center, a non-profit organization dedicated to bringing state-of-the-art therapies to the patient. The team has received support from the Swiss Innovation Agency, Innosuisse, to test and validate the efficacy of the therapy preclinically, in preparation for human clinical studies. Stroke is the third leading cause of disability worldwide with more than 80 million people living with long-term impairments as a result. Some strokes result in bleeding in the brain. Such hemorrhagic strokes can lead to severe cerebral vasospasm - an uncontrolled contraction of brain arteries - in the days that follow, depriving